**Question:** All of the following drugs are used in the management of MDR-TB under RNTCP except

A. Ethambutol
B. Rifampicin
C. Pyrazinamide
D. Linezolid

**Core Concept:**

MDR-TB stands for Multidrug-Resistant Tuberculosis, which is a form of tuberculosis (TB) that is resistant to the two most effective first-line TB drugs, isoniazid and rifampicin. The RNTCP (Revised National Tuberculosis Control Programme) is a public health program implemented in India to combat tuberculosis. The program recommends the use of a combination of drugs for the management of MDR-TB.

**Why the Correct Answer is Right:**

Linezolid is an antibiotic primarily used against Gram-positive bacteria, particularly those resistant to other antibiotics. Since Linezolid is not a drug used for the management of MDR-TB, it is the correct answer among the given options.

**Why Each Wrong Option is Incorrect:**

A. Ethambutol is a first-line drug used in the treatment of TB, specifically targeting the mycobacteria and preventing its growth. It is not specified that it is not part of the MDR-TB treatment regimen.

B. Rifampicin is also a first-line drug used in the treatment of TB, targeting the RNA polymerase enzyme in Mycobacterium tuberculosis, inhibiting DNA synthesis and killing the bacteria. It is a crucial drug in the treatment of both TB and MDR-TB.

C. Pyrazinamide is a first-line drug used in the treatment of TB, targeting the biosynthesis of pyrimidines in Mycobacterium tuberculosis, causing cell wall damage and inhibiting bacterial growth. It is included in the MDR-TB treatment regimen.

**Clinical Pearl:**

The treatment regimen for MDR-TB typically includes a combination of drugs specifically designed to target various aspects of Mycobacterium tuberculosis, ensuring effective drug therapy. The correct answer, Linezolid, is not part of this combination, highlighting the importance of using a treatment regimen tailored for MDR-TB and not merely combining drugs from different classes.